WebAug 29, 2024 · Results from the EMPEROR-Reduced trial, published simultaneously in the New England Journal of Medicine, 1 also show that empagliflozin prevents renal events and slows the process toward kidney ... WebAug 27, 2024 · The late breaking study is presented in a Hot Line session today at ESC Congress 2024 1 and published in the New England Journal of Medicine. 2. The EMPEROR-Reduced trial previously showed that the sodium–glucose co-transporter 2 (SGLT2) inhibitor empagliflozin reduced the risk of cardiovascular death or …
WikiJournalClub:Usable articles - Wiki Journal Club
WebMay 10, 2024 · Objective. The Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (PARAGON-HF) trial was designed to test if the use of sacubitril/valsartan in patients with HFpEF will lead to … WebSep 29, 2024 · CardioNerds Journal Club is a monthly forum for CardioNerds to discuss and breakdown recent publications on twitter and are produced with a corresponding infographic and detailed blog post. … fintru gasworks belfast
DELIVER - Wiki Journal Club
WebAug 26, 2024 · The effect of empagliflozin to attenuate eGFR decline during double-blind treatment was also present in patients with and without diabetes, although more … WebAug 30, 2024 · Now, investigators for the manufacturer-sponsored EMPEROR-Preserved trial ( NCT03059751) have randomized 5988 patients (mean age, 71 years; 45% women; … WebEMPEROR-Reduced were hospitalized for heart failure (HHF) within the preceding 12 months (≈31% versus 47%), and numerically more patients in EMPEROR-Reduced … essential by christoph